Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: A propensity-matched cohort study
Coronary Artery Disease Jan 03, 2018
Vuurmans T, et al. - This study was designed to test the hypothesis that revascularization with either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) leads to progression of renal failure, but improves survival compared with medical therapy in patients with chronic kidney disease (CKD). Findings revealed that progression of renal failure was higher in the first 3 months for CABG, but similar for all groups at 24 months in patients with coronary artery disease (CAD) and CKD who underwent the current practice of CABG, PCI, or are treated with medical therapy. In addition, in those treated with CABG vs PCI or medical therapy, lower 2-year mortality was noted.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries